Microfluidics Unveils New Biopharma Series of Processors at INTERPHEX 2009 Portable Aseptic, Enhanced and Basic models ideal for lab, clinical trial and small batch settings
Newton, Mass. - March 17, 2009 - Today at the INTERPHEX 2009 conference and trade show in New York, NY, Microfluidics unveiled an exciting new line of M-110EH-30 series processors specially engineered for the biopharmaceutical industry. Available in portable Aseptic, Enhanced and Basic models, these high shear fluid processors operate at pressures up to 30,000 psi and are ideal for lab research, clinical trials and small volume production needs.
Over 1,100 pharmaceutical companies - including 17 of the top 20 - rely on Microfluidizer® processors to achieve optimized nanosuspensions, nanoemulsions, liposomes, nanoencapsulation and cell disruption with highly repeatable results.
The M-110EH-30 is on display at Microfluidics exhibit booth #2214. For more capabilities and specifications, review the full press release.
In addition, visitors to the Microfluidics exhibit at INTERPHEX will have the opportunity to...
Collaborate with nanotechnology applications expert Thomai "Mimi" Panagiotou, Ph.D., Chief Technology Officer, on formulation-specific processing challenges and requirements See the extremely popular M-110P "plug and play" benchtop processor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.